Prestige Consumer Healthcare
PBH
#3940
Rank
A$4.50 B
Marketcap
A$91.56
Share price
1.27%
Change (1 day)
-29.97%
Change (1 year)

Prestige Consumer Healthcare (PBH) - Total debt

Total debt on the balance sheet as of September 2025 : A$1.56 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's total debt is A$1.56 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Prestige Consumer Healthcare - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2025-03-31A$1.67 B-4.1%
2024-03-31A$1.74 B-14.54%
2023-03-31A$2.04 B1.52%
2022-03-31A$2.01 B0.81%
2021-03-31A$1.99 B-30.72%
2020-03-31A$2.87 B13.86%
2019-03-31A$2.52 B-2.53%
2018-03-31A$2.59 B-9.59%
2017-03-31A$2.86 B35.39%
2016-03-31A$2.11 B3.34%
2015-03-31A$2.05 B103.4%
2014-03-31A$1.00 B8.12%
2013-03-31A$0.93 B-13.88%
2012-03-31A$1.08 B129.78%
2011-03-31A$0.47 B33.83%
2010-03-31A$0.35 B-34.95%
2009-03-31A$0.54 B21.23%
2008-03-31A$0.44 B-22.15%
2007-03-31A$0.57 B-18.82%
2006-03-31A$0.70 B10.2%
2005-03-31A$0.64 B224.82%
2004-03-31A$0.19 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
GlaxoSmithKline
GSK
A$35.92 B 2,192.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$91.60 B 5,745.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
A$9.90 B 532.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$68.94 B 4,299.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$2.93 M-99.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
A$48.20 B 2,976.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
A$54.11 B 3,352.96%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$123.07 B 7,753.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$4.63 B 195.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$19.48 B 1,143.11%๐Ÿ‡บ๐Ÿ‡ธ USA